Yuan-Chung Chen
Family Medicine · Henderson, NVNPI 1841226636
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,540 of the $12,540 with a category attached, or 84.1%. It is spread thinly across 38 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,827 and has fallen 68.2% since, to $1,215 in 2025. Among family medicine clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 162 payments — averaging $77.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$2K
- Amgen$2K
- AbbVie$2K
- Gilead$1K
- AstraZeneca$941
- Paratek Pharmaceuticals, Inc.$800
- plus $5K from 32 others
What the payments were for
- Consulting fees$2,00016%
- Food & beverage$10,54084%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,830
- UBRELVY$949
- AIMOVIG$928
- Epclusa$846
- NUZYRA$800
- QULIPTA$577
- FREESTYLE LIBRE 3$387
- Vascepa$363
- Prolastin-C Liquid$250
- Tymlos$250
- KRYSTEXXA$245
- FARXIGA$240
- REZDIFFRA$146
- QUVIVIQ$125
- VRAYLAR$125
- INJECTAFER$125
- AIRSUPRA$124
- AFREZZA$123
- REXULTI$123
- NUEDEXTA$122
How this compares
$12,540 in reported general payments places this provider in the 95th percentile of 902 family medicine providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 19 | $18,965 |
| NuedextaDextromethorphan Hbr/Quinidine | 13 | $10,035 |
| Morphine Sulfate ErMorphine Sulfate | 115 | $3,266 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 16 | $2,714 |
| Fentanyl | 19 | $2,662 |
| Oxycodone Hcl | 152 | $2,633 |
| Alendronate Sodium | 31 | $2,522 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 85 | $2,331 |
| Icosapent Ethyl | 12 | $2,287 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 63 | $1,735 |
| Eszopiclone | 13 | $1,110 |
| Ventolin HfaAlbuterol Sulfate | 16 | $893 |
| Pregabalin | 24 | $779 |
| Buprenorphine Hcl | 12 | $656 |
| Tramadol Hcl | 45 | $655 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $442 | $18,96519 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $124 | $10,03513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 902 family medicine providers in Nevada.
Other family medicine in Henderson
- Badi EghterafiHenderson$38K
- Gautham ReddyHenderson$17K
- Rita ChuangHenderson$15K
- Travis HailstoneHenderson$8K
- Elena GarciaHenderson$7K
- Naz WahabLas Vegas$563K
- Jerry CadeLas Vegas$180K
- Nilesh GokalLas Vegas$75K
- Bayo Curry-WinchellReno$74K
- Warren MagnusLas Vegas$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.